开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2024-08-05 1467de12m97暂无昵称来自江苏省

偏重的研究方向：低肌肉质量;临床
经验分享：记录一下，8月2号投的，现在是 submit to journal

35 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2024-08-13 柒1111111111 来自江苏省

偏重的研究方向：肌肉减少症
经验分享：8.13号完成投递，记录一下

34 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2024-07-30 ms1000001611028723 来自安徽省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：少肌症;胰岛素抵抗
经验分享：2024.7.16 submitted to journal；
2024..7.25 with editor；
后续跟进

42 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2023-10-17 ms4000001972100444 来自安徽省

审稿速度:24.0 | 投稿命中率:25.0
偏重的研究方向：肌少症;TI PS
经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊

75 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2024-08-12 medscizzz 来自河南省

投稿命中率:25.0
经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊

36 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2024-07-25 ms5000001538055549 来自江西省

无

38 0

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2024-07-12 1e0f77b7m68(暂无匿称) 来自广东省

审稿速度:3.0 | 投稿命中率:25.0
偏重的研究方向：肌衰;营养
经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。

23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。
期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。
期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。

总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。

57 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2024-06-19 松鼠茜来自重庆

审稿速度:24.0
经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多

62 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2024-06-17 146c6f9fm10暂无昵称来自江苏省

审稿速度:12.0
偏重的研究方向：低肌肉质量
经验分享：我第一次大修
第二次小修一个问题
第三次小修一个问题
现在RRC一周了，急。
上次小修是review后直接DIP，这次咋多了RRC。慌了

58 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2218493, encodeId=a36e2218493c2, content=偏重的研究方向：低肌肉质量;临床 经验分享：记录一下，8月2号投的，现在是 submit to journal, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=13995143031, createdName=1467de12m97暂无昵称, createdTime=Mon Aug 05 01:43:34 CST 2024, time=2024-08-05, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2219846, encodeId=5d1c2219846df, content=偏重的研究方向：肌肉减少症 经验分享：8.13号完成投递，记录一下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJB3XACgTSAb4UmoJXMDicGCp3FOeQOyhD2g2I27ic4BGic58uzrib3ZNKNB9BSIiaS6FpUXAHgL8rHvOw/132, createdBy=472d2325209, createdName=柒1111111111, createdTime=Tue Aug 13 11:36:56 CST 2024, time=2024-08-13, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2217473, encodeId=e82c221e473f0, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：少肌症;胰岛素抵抗 经验分享：2024.7.16 submitted to journal； 2024..7.25 with editor； 后续跟进, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=39d48361234, createdName=ms1000001611028723, createdTime=Tue Jul 30 09:09:30 CST 2024, time=2024-07-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163244, encodeId=081021632447b, content=审稿速度:24.0 | 投稿命中率:25.0 偏重的研究方向：肌少症;TI PS 经验分享：10.11投，6天过去了还是Submitted to Journal，一般要等多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=75, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77b58371430, createdName=ms4000001972100444, createdTime=Tue Oct 17 10:00:06 CST 2023, time=2023-10-17, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2219700, encodeId=d18c2219e00c1, content=投稿命中率:25.0 经验分享：1号就开始with editor，12天过去了，状态还是没变，好慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a9d65518978, createdName=medscizzz, createdTime=Mon Aug 12 11:27:37 CST 2024, time=2024-08-12, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2216727, encodeId=323f2216e2741, content=无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f7b9398747, createdName=ms5000001538055549, createdTime=Thu Jul 25 01:06:25 CST 2024, time=2024-07-25, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2214582, encodeId=4fea221458205, content=审稿速度:3.0 | 投稿命中率:25.0 偏重的研究方向：肌衰;营养 经验分享：看期刊的内容感觉要求不高，21年投过第一次，送审后被拒。审稿意见非常专业，也很严苛，改变了期刊要求不高的想法。 23年10月底再次尝试投稿，送审后1月份给到第一次返修，2个审稿人，每个都有10+的意见。对实验的专业描述、设计以及工作体量要求很高。第二次返修时间是3月份，1个审稿人，还是10+个意见，5月中旬修回，7月初接受。 期刊对工作量、创新性有高的要求；对实验原始数据要求非常高，必须有WB完整的图片。投稿周期相当长，不适合着急毕业的。 期刊的自引率主要来自投稿时必须引用它的一个学术规范，整体上自引率还好的。 总体来说，最开始对于该期刊要求不高的想法是被狠狠推翻了，如果研究的质量不错，也等得了漫长的投稿时间，该期刊是值得尝试的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/02/15/d7f932b1de8f984562a3c4338c7bcd30.jpg, createdBy=96381943169, createdName=1e0f77b7m68(暂无匿称), createdTime=Fri Jul 12 11:07:48 CST 2024, time=2024-07-12, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210628, encodeId=b72f221062836, content=审稿速度:24.0 经验分享：从投稿到最终接收，1次大修，三次小修，时长一年多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/X7UIfib9hL2a2gDVPa4mZNjBoRgGPmzSv3IHxok7EH8EXNF813dk9CTu1gnQozFCaw0FcDWGVNicmhwG2icV4DxZw/132, createdBy=09b35245389, createdName=松鼠茜, createdTime=Wed Jun 19 11:11:18 CST 2024, time=2024-06-19, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2210255, encodeId=eda622102552a, content=审稿速度:12.0 偏重的研究方向：低肌肉质量 经验分享：我第一次大修 第二次小修一个问题 第三次小修一个问题 现在RRC一周了，急。 上次小修是review后直接DIP，这次咋多了RRC。慌了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=74625165655, createdName=146c6f9fm10暂无昵称, createdTime=Mon Jun 17 10:10:50 CST 2024, time=2024-06-17, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204229, encodeId=0c82220422982, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：非常慢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9fc38275765, createdName=ms1000000251861924, createdTime=Sun May 12 11:56:00 CST 2024, time=2024-05-12, status=1, ipAttribution=北京)]

2024-05-12 ms1000000251861924 来自北京

审稿速度:24.0 | 投稿命中率:5.0
经验分享：非常慢

57 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务